EUVIMEDEUVIMED entdecken
Crossref

Ameliorating lung fibrosis and pulmonary function in diabetic mice: Therapeutic potential of mesenchymal stem cell

Maikeliya Aisanjiang, Wenshu Dai, Luna Wu, Yujia Yuan, Shuyun Liu, Guangneng Liao, Lan Li, Xiang Tong, Heteng Zhang, Younan Chen, Jingping Liu, Jingqiu Cheng und 2 weitere

Biochemical and Biophysical Research Communications · 2024

DOI: 10.1016/j.bbrc.2024.150495 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024. Verfasst von Maikeliya Aisanjiang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Key Laboratory of Transplant Engineering and Immunology, NHFPC, Frontiers Science Center for Di…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Pulmonary Fibrosis, Mesenchymal Stem Cell Transplantation, Mice, Inbred C57BL. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to investigate the potential of mesenchymal stem cells (MSCs) in alleviating diabetic lung injury by decreasing inflammation, fibrosis and recovering tissue macrophage homeostasis. To induce pulmonary injuries in an in vivo murine model, we utilized a streptozotocin (STZ), and high-fat diet (HFD) induced diabetic C57 mouse model. Subsequently, human umbilical cord-derived MSCs (hUC-MSCs) were administered through the tail vein on a weekly basis for a duration of 4 weeks. In addition, in vitro experiments involved co-culturing of isolated primary abdominal macrophages from diabetic mice and high glucose-stimulated MLE-12 cells with hUC-MSCs. The objective was to evaluate if hUC-MSCs co-culturing could effectively mitigate cell inflammation and fibrosis. Following hUC-MSCs injection, diabetic mice displayed enhanced pulmonary functional parameters, reduced pulmonary fibrosis, and diminished inflammation. Notably, the dynamic equilibrium of lung macrophages shifted from the M1 phenotype to the M2 phenotype, accompanied by a notable reduction in various indicators associated with inflammation and fibrosis. Results from cell co-culturing experiments further supported this trend, demonstrating a reduction in inflammatory and fibrotic indicators. In conclusion, our findings suggest that hUC-MSCs treatment holds promise in mitigating diabetic pulmonary injury by significantly reducing inflammation, fibrosis and maintain tissue macrophage homeostasis within the lungs. This study sheds light on the therapeutic potential of hUC-MSCs in managing diabetic complications affecting the pulmonary system.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, ExperimentalPulmonary FibrosisMesenchymal Stem Cell TransplantationMice, Inbred C57BLMesenchymal Stem CellsAnimalsHumansMiceMaleLungCoculture TechniquesMacrophages

Stichwörter der Autor:innen

Diabetes mellitusMacrophageMesenchymal stem cellPulmonary fibrosisROS

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Key Laboratory of Transplant Engineering and Immunology, NHFPC, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan Universi…
  • Animal experimental center of West China hospital, Sichuan University, Chengdu, China.
  • Sichuan Neo-Life Stem Cell Biotech Inc., Chengdu, China.
  • Department of Endocrinology and Metabolism, Center for Diabetes and Metabolism Research, West China Hospital, Sichuan University, Chengdu, China. Electronic address: wangchengshi@wchscu.cn.

Zitieren

APA

Aisanjiang, M., Dai, W., Wu, L., Yuan, Y., Liu, S., Liao, G., Li, L., Tong, X., Zhang, H., Chen, Y., Liu, J., Cheng, J., Wang, C., & Lu, Y. (2024). Ameliorating lung fibrosis and pulmonary function in diabetic mice: Therapeutic potential of mesenchymal stem cell. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2024.150495

Vancouver

Aisanjiang M, Dai W, Wu L, Yuan Y, Liu S, Liao G, et al. Ameliorating lung fibrosis and pulmonary function in diabetic mice: Therapeutic potential of mesenchymal stem cell. Biochemical and Biophysical Research Communications. 2024. doi:10.1016/j.bbrc.2024.150495

BibTeX
@article{Aisanjiang2024,
  author = {Aisanjiang, Maikeliya and Dai, Wenshu and Wu, Luna and Yuan, Yujia and Liu, Shuyun and Liao, Guangneng and Li, Lan and Tong, Xiang and Zhang, Heteng and Chen, Younan and Liu, Jingping and Cheng, Jingqiu and Wang, Chengshi and Lu, Yanrong},
  title = {Ameliorating lung fibrosis and pulmonary function in diabetic mice: Therapeutic potential of mesenchymal stem cell},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2024},
  doi = {10.1016/j.bbrc.2024.150495}
}
Kostenlos starten →